Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apyx Medical Corporation - Common Stock (NQ: APYX )

1.390 -0.030 (-2.11%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,510
Open 1.400
Bid (Size) 1.430 (35)
Ask (Size) 1.700 (70)
Prev. Close 1.420
Today's Range 1.380 - 1.470
52wk Range 0.9670 - 2.800
Shares Outstanding 34,322,749
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Look Ahead: Apyx Medical's Earnings Forecast
Via Benzinga
APYX Stock Earnings: Apyx Medical Beats EPS, Beats Revenue for Q2 2024
APYX stock results show that Apyx Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
-11.75%
-11.75%
1 Month
-12.03%
-12.03%
3 Month
+17.44%
+17.44%
6 Month
+2.96%
+2.96%
1 Year
-30.15%
-30.15%

More News

Read More
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
From Apyx Medical Corporation
Via Business Wire
Apyx Medical's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
APYX Stock Earnings: Apyx Medical Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Announces Board Leadership Transition
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
From Apyx Medical Corporation
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Crude Oil Moves Lower; Accenture Shares Tumble After Q2 Results
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Gold Gains 1%; Micron Posts Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
APYX Stock Earnings: Apyx Medical Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
From Apyx Medical Corporation
Via Business Wire
Earnings Scheduled For March 21, 2024
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
From Apyx Medical Corporation
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.